Darina Hrdličková, chairwoman of the Association of Contract Research Organizations in the Czech Republic (ACRO-CZ), gives an overview of her new priorities and mission since taking over the position in 2018, and how dedicated she is to showcase the strengths of the Czech healthcare system and the advantages of the Czech Republic as a clinical trials destination. Whilst explaining the undergoing projects of ACRO-CZ, Hrdličková also exposes her concerns about the struggle to find sponsors for clinical research in the country.
In my opinion, the regulatory authority, the State Institute for Drug Control (SUKL), is strict but fair
